NCT00004197 Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00004192 Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00004189 Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00004179 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00004171 Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00004169 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease Status COMPLETED Phase PHASE2
NCT00004162 Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00004157 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Status COMPLETED Phase PHASE2
NCT00004145 Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00004132 Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00004114 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer Status WITHDRAWN Phase PHASE1
NCT00004112 Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00004107 Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE1/PHASE2
NCT00004106 Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome Status TERMINATED Phase PHASE2
NCT00004105 Combination Chemotherapy in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00004101 Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00004086 Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer Status UNKNOWN Phase PHASE1
NCT00004084 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00004075 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE1
NCT00004061 Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer Status COMPLETED Phase PHASE2